RNXT RenovoRx Inc

P/E --

Forward P/E --

Price/Sales 29.46

Beta 0.974

Div Yield --

Market Cap --

Company Analysis

Latest News

November 04, 2026

RenovoRx Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026

RenovoRx Inc is expected to report a third-quarter consensus revenue of $1.06 million and an EPS of -$0.05, while the stock currently trades around $1.33...